Bakkt (BKKT) 10-K/A 21 May 21 2020 FY Annual report (amended) Financial data

Cover Page

Cover Page - USD ($)	5 Months Ended
	Dec. 31, 2020	Mar. 29, 2021
Document Information [Line Items]
Document Type	10-K/A
Amendment Flag	true
Document Period End Date	Dec. 31, 2020
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2020
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Registrant Name	VPC IMPACT ACQUISITION HOLDINGS
Entity Interactive Data Current	Yes
Current Fiscal Year End Date	--12-31
Entity Central Index Key	0001820302
Entity File Number	001-39544
Entity Incorporation, State or Country Code	E9
Entity Tax Identification Number	98-1550750
Entity Address, Address Line One	Victory Park Capital Advisors, LLC
Entity Address, Address Line Two	150 North Riverside Plaza
Entity Address, Address Line Three	Suite 5200
Entity Address, City or Town	Chicago
Entity Address, State or Province	IL
Entity Address, Postal Zip Code	60606
City Area Code	312
Local Phone Number	701-1777
Document Annual Report	true
Document Transition Report	false
Entity Shell Company	true
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Public Float	$ 223,907,781.60
ICFR Auditor Attestation Flag	false
Amendment Description	References throughout this Amendment No. 1 to the Annual Report on Form 10-K to “we,” “us,” the “Company” or “our company” are to VPC Impact Acquisition Holdings, unless the context otherwise indicates. This Amendment No. 1 (“Amendment No. 1”) to the Annual Report on Form 10-K/A amends the Annual Report on Form 10-K of VPC Impact Acquisition Holdings, as of December 31, 2020 and for the period from July 31, 2020 (Inception) through December 31, 2020, as filed with the Securities and Exchange Commission (“SEC”) on March 31, 2021 (the “Original Filing”). On April 12, 2021, the staff of the Securities and Exchange Commission (the “SEC Staff”) issued a public statement entitled “Staff Statement on Accounting and Reporting Considerations for Warrants issued by Special Purpose Acquisition Companies (“SPACs”)” (the “SEC Staff Statement”). In the SEC Staff Statement, the SEC Staff expressed its view that certain terms and conditions common to SPAC warrants may require the warrants to be classified as liabilities rather than equity on a SPAC’s balance sheet. Since their issuance on September 25, 2020 at the time of the Company’s initial public offering, our warrants have been accounted for as equity within our balance sheet, and after discussion and evaluation, we have concluded that our warrants should be presented as liabilities with subsequent fair value remeasurement. Therefore, the Company, in consultation with its audit committee, concluded that its previously issued financial statements as of December 31, 2020 and for the period from July 31, 2020 (inception) through December 31, 2020 (the “Affected Period”) should be restated because of a misapplication in the guidance around accounting for certain of our outstanding warrants to purchase common stock and should no longer be relied upon. Historically, our warrants to purchase common stock (the “Warrants”) were reflected as a component of equity as opposed to liabilities on the balance sheets and the statements of operations did not include the subsequent non-cash changes in estimated fair value of the Warrants, based on our application of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 815-40, Derivatives and Hedging, Contracts in Entity’s Own Equity (“ASC 815-40). The views expressed in the SEC Staff Statement were not consistent with the Company’s historical interpretation of the specific provisions within its warrant agreement and the Company’s application of ASC 815-40 to the warrant agreement. We reassessed our accounting for Warrants issued on September 25, 2020, in light of the SEC Staff’s published views. Based on this reassessment, we determined that the Warrants should be classified as liabilities measured at fair value upon issuance, with subsequent changes in fair value reported in our Statement of Operations each reporting period. We are filing this Amendment No. 1 to amend the disclosure in the Risk Factors under Item 1A, the Management’s Discussion and Analysis of Financial Condition and Results of Operation described in Item 7, Financial Statements and Supplementary Data described in Item 8 and Controls and Procedures described in Item 9A, in the Original Filing to give effect to the change in accounting for the Warrants. The change in accounting for the Warrants did not have any impact on our liquidity, cash flows, revenues or costs of operating our business and the other non-cash adjustments to the Financial Statements, in the Affected Period or in any of the periods included in Item 8, Financial Statements and Supplementary Data in this filing. The change in accounting for the Warrants does not impact the amounts previously reported for the Company’s cash and cash equivalents, investments held in trust account, operating expenses or total cash flows from operations for the Affected Period.In accordance with Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), Item 1A, Risk Factors, is hereby amended to add additional risk factors, and Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operation, Item 8, Financial Statements and Supplementary Data, and Item 9A, Controls and Procedures of the Original Filing are hereby amended and restated in their entirety. This Amendment No. 1 should be read in conjunction with the Original Filing and with our other filings with the SEC subsequent to the Original Filing. This Amendment No. 1 does not reflect events occurring after the filing of the Original Filing, and, except as described above, does not modify or update any other disclosures in the Original Filing. In addition, the Company’s Chief Executive Officer and Chief Financial Officer have provided new certifications dated as of the date of this filing in connection with this Form 10K/A (Exhibits 31.1, 31.2, 32.1 and 32.2).
Class A [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		20,732,202
Trading Symbol	VIH
Security Exchange Name	NASDAQ
Title of 12(b) Security	Class A ordinary shares, $0.0001 par value per share
Class B [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		5,184,300
Capital Units [Member]
Document Information [Line Items]
Trading Symbol	VIHAU
Security Exchange Name	NASDAQ
Title of 12(b) Security	Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one Warrant to purchase one Class A ordinary share
Warrant [Member]
Document Information [Line Items]
Trading Symbol	VIHAW
Security Exchange Name	NASDAQ
Title of 12(b) Security	Warrants to purchase Class A ordinary shares

Consolidated Balance Sheet

Consolidated Balance Sheet	Dec. 31, 2020USD ($)
Current assets
Cash	$ 1,177,678
Prepaid expenses	234,959
Total Current Assets	1,412,637
Cash and marketable securities held in Trust Account	207,376,213
TOTAL ASSETS	208,788,850
Current liabilities
Accrued expenses	893,415
Accrued offering costs	2,230
Total Current Liabilities	895,645
Deferred underwriting fee payable	7,258,021
Warrant liabilities	22,513,065
Total Liabilities	30,666,731
Commitments and Contingencies
Class A ordinary shares subject to possible redemption, 17,312,211 shares at $10.00 per share	173,122,110
Shareholders' Equity
Preference shares, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding	0
Additional paid-in capital	9,860,338
Accumulated deficit	(4,861,190)
Total Shareholders' Equity	5,000,009
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	208,788,850
Class A [Member]
Shareholders' Equity
Ordinary shares	343
Class B [Member]
Shareholders' Equity
Ordinary shares	$ 518

Consolidated Balance Sheet (Par

Consolidated Balance Sheet (Parenthetical)	Dec. 31, 2020$ / sharesshares
Temporary Equity, Shares Authorized	17,312,211
Temporary Equity, Par Value | $ / shares	$ 10
Preferred Stock, Par Value | $ / shares	$ 0.0001
Preferred Stock, Shares Authorized	1,000,000
Preferred Stock, Shares Issued	0
Preferred Stock, Shares Outstanding	0
Class A [Member]
Common Stock, Par Value | $ / shares	$ 0.0001
Common Stock, Shares Authorized	200,000,000
Common Stock, Shares, Issued	3,424,991
Common Stock, Shares, Outstanding	3,424,991
Common Stock Subject To Possible Redemption	17,312,211
Class B [Member]
Common Stock, Par Value | $ / shares	$ 0.0001
Common Stock, Shares Authorized	20,000,000
Common Stock, Shares, Issued	5,184,300
Common Stock, Shares, Outstanding	5,184,300

Consolidated Statement of Opera

Consolidated Statement of Operations	5 Months Ended
	Dec. 31, 2020USD ($)$ / sharesshares
Formation and operating costs	$ 1,006,862
Loss from operations	(1,006,862)
Other income:
Interest earned on marketable securities held in Trust Account	4,193
Transaction Costs allocable to warrant liabilities	(768,391)
Change in fair value of warrant liabilities	(3,090,130)
Net Loss	(4,861,190)
Class A [Member]
Other income:
Interest earned on marketable securities held in Trust Account	$ 4,193
Weighted average shares outstanding | shares	20,737,202
Basic and diluted net income per share | $ / shares	$ 0
Class B [Member]
Loss from operations	$ (4,865,383)
Other income:
Net Loss	$ (4,861,190)
Weighted average shares outstanding | shares	5,184,300
Basic and diluted net income per share | $ / shares	$ (0.94)

Consolidated Statement of Chang

Consolidated Statement of Changes in Shareholders' Equity - USD ($)	Total	Class B [Member]	Ordinary Shares [Member]Class A [Member]	Ordinary Shares [Member]Class B [Member]	Additional Paid in Capital [Member]	Accumulated Deficit [Member]
Beginning balance at Jul. 30, 2020	$ 0		$ 0	$ 0	$ 0	$ 0
Beginning balance, shares at Jul. 30, 2020			0	0
Beginning balance at Jul. 30, 2020	0		$ 0	$ 0	0	0
Beginning balance, shares at Jul. 30, 2020			0	0
Issuance of Class B ordinary shares to Sponsor	25,000		$ 0	$ 575	24,425	0
Issuance of Class B ordinary shares to Sponsor, shares			0	5,750,000
Sale of 20,737,202 Units, net of underwriting discounts, fair value of Public warrants and offering costs	$ 182,958,309		$ 2,074	$ 0	182,956,235	0
Sale of 20,737,202 Units, net of underwriting discounts, fair value of Public warrants and offering costs, Shares			20,737,202	0
Forfeiture of 565,700 Sponsor shares				$ (57)	57
Forfeiture of 565,700 Sponsor shares, Shares	565,700			(565,700)
Ordinary shares subject to possible redemption	$ (173,122,110)		$ (1,731)	$ 0	(173,120,379)	0
Ordinary shares subject to possible redemption, Shares			(17,312,211)	0
Net loss	(4,861,190)	$ (4,861,190)	$ 0	$ 0	0	(4,861,190)
Ending balance at Dec. 31, 2020	$ 5,000,009		$ 343	$ 518	$ 9,860,338	$ (4,861,190)
Ending balance, shares at Dec. 31, 2020			3,424,991	5,184,300

Consolidated Statement of Cha_2

Consolidated Statement of Changes in Shareholders' Equity (Parenthetical)	5 Months Ended
	Dec. 31, 2020shares
Share based compensation other than employee stock scheme shares forfeited during the period	565,700
Ordinary Shares [Member] | Class A [Member]
Number of units sold	20,737,202

Consolidated Statement of Cash

Consolidated Statement of Cash Flows	5 Months Ended
	Dec. 31, 2020USD ($)
Cash Flows from Operating Activities:
Net (loss)	$ (4,861,190)
Adjustments to reconcile net (loss) to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account	(4,193)
Formation costs paid by Sponsor in exchange for Founder shares	6,606
Change in fair value of warrant liabilities	3,090,130
Transaction costs allocable to warrant liabilities	768,391
Changes in operating assets and liabilities:
Prepaid expenses	(234,959)
Accrued expenses	893,415
Net cash used in operating activities	(341,800)
Cash Flows from Investing Activities:
Investment of cash in Trust Account	(207,372,020)
Net cash used in investing activities	(207,372,020)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid	203,224,580
Proceeds from sale of Private Placements Warrants	6,147,440
Repayment of promissory note – related party	(82,729)
Payment of offering costs	(397,793)
Net cash provided by financing activities	208,891,498
Net Change in Cash	1,177,678
Cash – Beginning
Cash – Ending	1,177,678
Non-Cash Investing and Financing Activities:
Change in value of Class A ordinary shares subject to possible redemption	(1,760,900)
Initial classification of Class A ordinary shares subject to possible redemption	174,883,010
Initial classification of warrant liabilities	20,960,000
Deferred underwriting fee payable	7,258,021
Payment of offering costs through promissory note	82,729
Offering costs paid by Sponsor in exchange for issuance of Founder shares	18,394
Offering costs included in accrued offering costs	2,230
Forfeiture of Founder Shares	$ (57)

Description of Organization and

Description of Organization and Business Operations	5 Months Ended
	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Organization and Business Operations	NOTE 1—DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS VPC Impact Acquisition Holdings (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on July 31, 2020. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (a “Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. The Company has one subsidiary, Pylon Merger Company LLC, a direct wholly owned subsidiary of the Company formed in Delaware on December 18, 2020. As of December 31, 2020, the Company had not commenced any operations. All activity for the period from July 31, 2020 (inception) through December 31, 2020 relates to the Company’s formation, its initial public offering (“Initial Public Offering”), which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating The registration statement for the Company’s Initial Public Offering was declared effective on September 22, 2020. On September 25, 2020 the Company consummated the Initial Public Offering of 20,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units sold, the “Public Shares”), generating gross proceeds of $200,000,000 which is described in Note 4 Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 6,000,000 warrants (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to VPC Impact Acquisition Holdings Sponsor, LLC (the “Sponsor”), generating gross proceeds of $6,000,000, which is described in Note 5 On September 29, 2020, the underwriters notified the Company of their intention to partially exercise their over-allotment option on October 1, 2020. As such, on October 1, 2020, the Company consummated the sale of an additional 737,202 Units, at $10.00 per Unit, and the sale of an additional 147,440 Private Placement Warrants, at $1.00 per Private Warrant, generating total gross proceeds of $7,519,460. Transaction costs charged to equity amounted to $11,906,606, consisting of $4,147,440 of underwriting fees, $7,258,021 of deferred underwriting fees and $501,145 of other offering costs. In addition, at September 25, 2020 cash of $1,205,178 was held outside of the Trust Account (as defined below) and is available for working capital purposes. Following the closing of the Initial Public Offering on September 25, 2020 and the partial exercise of the underwriter’s over-allotment on October 1, 2020, an amount of $207,372,020 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a-7 The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The stock exchange listing rules require that the Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account). The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination. The Company will provide the holders of the public shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their public shares upon the completion of the Business Combination, either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares, equal to the aggregate amount then on deposit in the Trust Account, calculated as of two business days prior to the consummation of the Business Combination (initially $10.00 per Public Share), including interest (which interest shall be net of taxes payable), divided by the number of then issued and outstanding public shares, subject to certain limitations as described in the prospectus. The per-share 7 The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 and, if the Company seeks shareholder approval, it receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the Company. If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 6 Notwithstanding the foregoing, if the Company seeks shareholder approval of the Business Combination and the Company does not conduct redemptions pursuant to the tender offer rules, a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares without the Company’s prior written consent. The Sponsor has agreed (a) to waive its redemption rights with respect to any Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (ii) with respect to any other provision relating to shareholders’ rights or pre-initial per-share The Company will have until September 25, 2022 to consummate a Business Combination (the “Combination Period”). However, if the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the Public Shares, at a per-share The Sponsor has agreed to waive its rights to liquidating distributions from the Trust Account with respect to the Founder Shares it will receive if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor or any of its respective affiliates acquire Public Shares, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 7 In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (1) $10.00 per Public Share and (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share, due to reductions in the value of trust assets, in each case net of the interest that may be withdrawn to pay taxes. This liability will not apply to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Francis Liquidity and Capital Resources As of December 31, 2020, the Company had approximately $1.2 million in its operating bank accounts and working capital of approximately $0.5 million. Prior to the completion of the Initial Public Offering, the Company’s liquidity needs had been satisfied through a contribution of $25,000 from Sponsor to cover for certain formation and offering costs in exchange for the issuance of the Founder Shares, the loan of up to $300,000 from the Sponsor pursuant to the Note (see Note 6 6 Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.

Restatement of Previously Issue

Restatement of Previously Issued Financial Statements	5 Months Ended
	Dec. 31, 2020
Restatement Of Previously Issued Financial Statements [Abstract]
Restatement of Previously Issued Financial Statements	NOTE 2—RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS The Company previously accounted for its outstanding Public Warrants (as defined in Note 4) and Private Placement Warrants issued in connection with its Initial Public Offering as components of equity instead of as derivative liabilities. The warrant agreement governing the warrants includes a provision that provides for potential changes to the settlement amounts dependent upon the characteristics of the holder of the warrant. In addition, the warrant agreement includes a provision that in the event of a tender or exchange offer made to and accepted by holders of more than 50% of the outstanding shares of a single class of common shares, all holders of the warrants would be entitled to receive cash for their warrants (the “tender offer provision”). On April 12, 2021, the SEC released a Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (the “SEC Staff Statement”). Specifically, the SEC Staff Statement focused on certain settlement terms and provisions related to certain tender offers following a business combination, which terms are similar to those contained in the warrant agreement governing our warrants. Following the SEC Staff Statement, the Company’s management further evaluated the warrants under Accounting Standards Codification (“ASC”) Subtopic 815-40, Contracts in Entity’s Own Equity. ASC Section 815-40-15 addresses equity versus liability treatment and classification of equity-linked financial instruments, including warrants, and states that a warrant may be classified as a component of equity only if, among other things, the warrant is indexed to the issuer’s common stock. Under ASC Section 815-40-15, a warrant is not indexed to the issuer’s common stock if the terms of the warrant require an adjustment to the exercise price upon a specified event and that event is not an input to the fair value of the warrant. Based on management’s evaluation, the Company’s audit committee, in consultation with management and after discussion with the Company’s independent registered public accounting firm, concluded that the Company’s Private Placement Warrants are not indexed to the Company’s common shares in the manner contemplated by ASC Section 815-40-15 As a result of the above, the Company should have classified the warrants as derivative liabilities in its previously issued financial statements. Under this accounting treatment, the Company is required to measure the fair value of the warrants at the end of each reporting period and recognize changes in the fair value from the prior period in the Company’s operating results for the current period. The Company’s accounting for the warrants as components of equity instead of as derivative liabilities did not have any effect on the Company’s previously reported operating expenses, cash flows or cash. Balance Sheet as of September 25, 2020 (audited) As Reported Restatement As Restated Warrant Liabilities $ — $ 20,960,000 $ 20,960,000 Total Liabilities 7,002,230 20,960,000 27,962,230 Class A ordinary shares subject to possible redemption 189,517,240 (20,960,000 ) 168,557,240 Class A ordinary shares 105 209 314 Additional paid-in capital $ 5,005,991 $ 2,914,781 $ 7,920,772 Accumulated deficit $ (6,606 ) $ (2,914,990 ) $ (2,921,596 ) Total Shareholders’ Equity $ 5,000,008 $ — $ 5,000,008 Number of shares subject to possible redemption 18,951,724 (2,096,000 ) 16,855,724 Balance Sheet as of September 30, 2020 (unaudited) Warrant Liabilities $ — $ 21,060,000 $ 21,060,000 Total Liabilities 7,002,230 21,060,000 28,062,230 Class A ordinary shares subject to possible redemption 189,506,470 (21,060,000 ) 168,446,470 Class A ordinary shares 105 211 316 Additional paid-in capital $ 5,016,761 $ 3,014,779 $ 8,031,540 Accumulated deficit (17,379 ) (3,014,990 ) (3,032,369 ) Total Shareholders’ Equity $ 5,000,005 $ — $ 5,000,005 Number of shares subject to possible redemption 18,950,647 (2,106,000 ) 16,844,647 Balance Sheet as of December 31, 2020 (audited) Warrant Liabilities $ — $ 22,513,065 $ 22,513,065 Total Liabilities 8,153,666 22,513,065 30,666,731 Class A ordinary shares subject to possible redemption 195,635,180 (22,513,070 ) 173,122,110 Class A ordinary shares 118 225 343 Additional paid-in capital $ 6,002,037 $ 3,858,301 $ 9,860,338 Accumulated deficit $ (1,002,669 ) $ (3,858,521 ) $ (4,861,190 ) Total Shareholders’ Equity $ 5,000,004 $ 5 $ 5,000,009 Number of shares subject to possible redemption 19,563,518 (2,251,306 ) 17,312,211 Statement of Operations for the period from July 31, 2020 (Inception) As Reported Restatement As Restated Transaction costs allocable to warrant liabilities $ — $ (754,990 ) $ (754,990 ) Change in fair value of warrant liabilities — (2,260,000 ) (2,260,000 ) Net loss $ (17,379 ) $ (3,014,990 ) $ (3,032,369 ) Basic and diluted net loss per share, Class B $ 0.00 $ (0.58 ) $ (0.58 ) Statement of Operations for the period from July 31, 2020 (Inception) Transaction costs allocable to warrant liabilities $ — $ (768,391 ) $ (768,391 ) Change in fair value of warrant liabilities — (3,090,130 ) (3,090,130 ) Net loss $ (1,002,669 ) $ (3,858,521 ) $ (4,861,190 ) Basic and diluted net (loss) per ordinary share, Class B $ (0.19 ) $ (0.75 ) $ (0.94 ) Statement of Cash Flows for the period from July 31, 2020 (inception) As Reported Restatement As Restated Net loss $ (17,379 ) $ (3,014,990 ) $ (3,032,369 ) Transaction costs allocable to warrant liabilities $ — $ (754,990 ) $ (754,990 ) Change in fair value of warrant liabilities — (2,260,000 ) (2,260,000 ) Initial classification of Class A Ordinary Shares subject to possible redemption 189,517,240 (20,960,000 ) 168,557,240 Change in value of Class A Ordinary Shares subject to possible redemption (10,770 ) (100,000 ) (110,770 ) Initial classification of warrant liability $ — $ 20,960,000 $ 20,960,000 Statement of Cash Flows for the period from July 31, 2020 (inception) As Reported Restatement As Restated Net loss $ (1,002,669 ) $ (3,858,521 ) $ (4,861,190 ) Transaction costs allocable to warrant liabilities $ — $ (768,391 ) $ (768,391 ) Change in fair value of warrant liabilities — (3,090,130 ) (3,090,130 ) Initial classification of Class A Ordinary Shares subject to possible redemption 196,631,240 (21,748,230 ) 174,883,010 Change in value of Class A Ordinary Shares subject to possible redemption (996,060 ) (764,840 ) (1,760,900 ) Initial classification of warrant liability $ — $ 20,960,000 $ 20,960,000

Summary of Significant Accounti

Summary of Significant Accounting Policies	5 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 3 Basis of Presentation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC. As described in Note 2—Restatement of Previously Issued Financial Statements, the Company’s consolidated financial statements for the year ended December 31, 2020 (collectively, the “Affected Period”), are restated in this Annual Report on Form 10-K/A (Amendment No. 1) (this “Annual Report”) to correct the misapplication of accounting guidance related to the Company’s warrants in the Company’s previously issued audited and unaudited condensed consolidated financial statements for such periods. The restated consolidated financial statements are indicated as “Restated” in the audited consolidated financial statements and accompanying notes, as applicable. See Note 2—Restatement of Previously Issued Financial Statements for further discussion. Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging Use of Estimates The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. One of the more significant accounting estimates included in these consolidated financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2020. Investments held in Trust Account The Company’s portfolio of investments held in trust is comprised solely of U.S. Treasury money market funds, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these investments are included in interest earned on marketable securities held in Trust Account in the accompanying consolidated statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at December 31, 2020, 17,312,211 Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ equity section of the Company’s consolidated balance sheet. Warrant Liability (Restated) The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as a liability at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the consolidated statements of operations. The fair value of the public warrants were initially estimated using the Option Pricing Method with subsequent remeasurements utilizing the trading stock price, whereas the private warrants were estimated using a Option Pricing Method approach for all periods (see Note 10). Offering Costs Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that are directly related to the Initial Public Offering. Offering costs amounting to $11,906,606 were charged to shareholders’ equity upon the completion of the Initial Public Offering. Derivative Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The 10,368,601 warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the 6,147,440 Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s consolidated statement of operations. The fair value of the Public Warrants issued in connection with the Public Offering and Private Placement Warrants were initially measured at fair value using a Option Pricing simulation model and subsequently, the fair value of the Private Placement Warrants have been estimated using a Black Scholes simulation model each measurement date. The fair value of Public Warrants issued in connection with the Initial Public Offering have subsequently been measured based on the listed market price of such warrants. Income Taxes The Company accounts for income taxes under ASC Topic 740, “Income Taxes,” which prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of December 31, 2020, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented. The Company does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Net Loss Per Ordinary Share (Restated) The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding for the period. The calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) Private Placement Warrants since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants are exercisable to purchase 16,516,041 shares of Class A ordinary shares in the aggregate. The Company’s consolidated statement of operations includes a presentation of income (loss) per share for ordinary shares subject to possible redemption in a manner similar to the two-class non-redeemable non-redeemable non-redeemable The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts): For the Period from Through 2020 Redeemable Class A Ordinary Shares Numerator: Earnings allocable to Redeemable Class A Ordinary Shares Interest Income $ 4,193 Redeemable Net Earnings $ 4,193 Denominator: Weighted Average Redeemable Class A Ordinary Shares Redeemable Class A Ordinary Shares, Basic and Diluted 20,737,202 Net Income Per Share/Basic and Diluted Redeemable Class A Ordinary Shares $ — Non-Redeemable Numerator: Net Income (Loss) minus Redeemable Net Earnings Net Income (Loss) $ (4,861,190 ) Redeemable Net Earnings $ (4,193 ) Non-Redeemable $ (4,865,383 ) Denominator: Weighted Average Non-Redeemable Class B Ordinary Share s Non-Redeemable 5,184,300 Net Loss Per Share/Basic and Diluted Non-Redeemable $ (0.94 ) As of December 31, 2020, The Company has not considered the effect of the warrants sold in the Initial Public Offering and Private Placement to purchase an aggregate of 16,000,000 shares of Class A common stock in the calculation of diluted loss per share, since their inclusion would be antidilutive under the treasury stock method. As a result, diluted loss per common share is the same as basic loss per common share for the period presented. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limits of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities other than the warrant liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the Company’s consolidated balance sheet, primarily due to their short-term nature. Fair Value Measurements (Restated) Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. Derivative Financial Instruments (Restated) The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s consolidated financial statements.

Initial Public offering

Initial Public offering	5 Months Ended
	Dec. 31, 2020
Equity [Abstract]
Initial Public Offering	NOTE 4 Pursuant to the Initial Public Offering, the Company sold 20,000,000 Units, at a purchase price of $10.00 per Unit. In connection with the underwriters’ partial exercise of the over-allotment option on October 1, 2020, the Company sold an additional 737,202 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one Class A ordinary share and one-half (see Note 9

Private Placement

Private Placement	5 Months Ended
	Dec. 31, 2020
Equity [Abstract]
Private Placement	NOTE 5 Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 6,000,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $6,000,000. In connection with the underwriters’ partial exercise of the over-allotment option on October 1, 2020, the Company sold an additional 147,440 Private Placement Warrants, at a purchase price of $1.00 per Private Placement Warrants, for an aggregate purchase price of $147,440. Each Private Placement Warrant is exercisable to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 9

Related Party Transactions

Related Party Transactions	5 Months Ended
	Dec. 31, 2020
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 6 Founder Shares On August 3, 2020, the Sponsor paid $25,000 to cover certain offering and formation costs of the Company in consideration for 5,750,000 Class B ordinary shares (the “Founder Shares”). In September 2020, the Sponsor transferred an aggregate of 60,000 Founder Shares to members of the Company’s board of directors, resulting in the Sponsor holding 5,690,000 Founder Shares. The Founder Shares included an aggregate of up to 750,000 shares that were subject to forfeiture depending on the extent to which the underwriters’ over-allotment option was exercised, so that the number of Founder Shares would equal, on an as-converted The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earliest of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, 30-trading Promissory Note—Related Party On August 3, 2020, the Company issued an unsecured promissory note (the “Promissory Note”) to the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $300,000. The Promissory Note was non-interest Administrative Services Agreement Commencing on September 25, 2020, the Company entered into an agreement to pay the Sponsor up to $10,000 per month for office space, utilities, secretarial and administrative support services. Upon completion of a Business Combination or its liquidation, the Company will cease paying these monthly fees. As of December 31, 2020, $30,000 were earned and remained unpaid in the accrued expenses line item on the consolidated balance sheet. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors will loan, and have the means to provide the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $ 1,500,000 of notes may be converted upon completion of a Business Combination into warrants at a price of $1.00 per warrant. Such warrants would be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of December 31, 2020, the Company had no outstanding borrowings under the Working Capital Loans.

Commitments and Contingencies

Commitments and Contingencies	5 Months Ended
	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 7 Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 Registration and Shareholders Rights Pursuant to a registration rights agreement entered into on September 22, 2020, the holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of the Working Capital Loans) are entitled to registration rights requiring the Company to register a sale of any of its securities held by them. The holders of these securities will be entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters are entitled to a deferred fee of $0.35 per Unit, or $7,258,021 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

Shareholders' Equity

Shareholders' Equity	5 Months Ended
	Dec. 31, 2020
Equity [Abstract]
Shareholders' Equity	NOTE 8 Preference Shares Class A Ordinary Shares Class B Ordinary Shares . Only holders of the Class B ordinary shares will have the right to vote on the appointment of directors prior to the Business Combination. Holders of Class A ordinary shares and Class B ordinary shares will vote together as a single class on all other matters submitted to a vote of shareholders, except as required by law and except that in a vote to continue the Company in a jurisdiction outside the Cayman Islands, holders of Class B ordinary shares will have ten votes per share and holders of Class A ordinary shares will have one vote per share. The Class B ordinary shares will automatically convert into Class A ordinary shares concurrently with or immediately following the consummation of a Business Combination on a one-for-one one-for-one

Warrants

Warrants	5 Months Ended
	Dec. 31, 2020
Warrants [Abstract]
Warrants	NOTE 9 Warrants The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the Class A ordinary shares underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable and the Company will not be obligated to issue a Class A ordinary share upon exercise of a warrant unless the Class A ordinary share issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. The Company has agreed that as soon as practicable, but in no event later than 15 business days, after the closing of a Business Combination, it will use its best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement and a current prospectus relating thereto until the expiration of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the sixtieth (60th) business day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00 . • in whole and not in part; • at a price of $0.01 per warrant; • upon a minimum of 30 days’ prior written notice of redemption; and • if, and only if, the reported closing price of the Company’s Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00 • in whole and not in part; • at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption; provided • if, and only if, the last reported sale price (the “closing price”) of the Company’s Class A ordinary shares equals or exceeds $10.00 per Public Share (as adjusted) for any 20 trading days within the 30-trading • if the closing price of the Class A ordinary shares for any 20 trading days within a 30-trading If the Company calls the Public Warrants for redemption, as described above, its management will have the option to require any holder that wishes to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of ordinary shares issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Class A ordinary shares during the 10 trading day period starting on the trading day prior to the day on which the Company consummates a Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable,

Fair Value Measurements

Fair Value Measurements	5 Months Ended
	Dec. 31, 2020
Fair Value Disclosures [Abstract]
Fair Value Measurements	NOTE 10 The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. At December 31, 2020, assets held in the Trust Account were comprised of $207,376,213 in money market funds which are invested primarily in U.S. Treasury Securities. During the year ended December 31, 2020, the Company did not withdraw any interest income from the Trust Account. The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at December 31, 2020 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level December 31, 2020 Assets: Investments held in Trust Account—U.S. Treasury Securities Money Market Fund 1 $ 207,376,213 Liabilities: Warrant Liability—Public Warrants 1 $ 11,509,147 Warrant Liability—Private Placement Warrants 3 $ 11,003,918 The Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the balance sheet. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the consolidated statement of operations. Initial Measurement The Company established the initial fair value for the Warrants on September 25, 2020, the date of the Company’s Initial Public Offering, using an Option Pricing Method for the Public Warrants and a Black-Scholes Model for the Private Placement Warrants. The Company allocated the proceeds received from (i) the sale of Units (which is inclusive of one share of Class A ordinary shares and one-fourth of one Public Warrant), and (ii) the sale of Private Placement Warrants, first to the Warrants based on their fair values as determined at initial measurement, with the remaining proceeds allocated to Class A ordinary shares subject to possible redemption, Class A ordinary shares and Class B ordinary shares based on their relative fair values at the initial measurement date. The Warrants were classified as Level 3 at the initial measurement date due to the use of unobservable inputs. The key inputs into the Option Pricing Method for the Public Warrants were as follows at initial measurement: Input September 25, 2020 September 30, Risk-free interest rate 0.26 % 0.28 % Trading days per year 252 252 Expected volatility 24.0 % 24.0 % Exercise price $ 11.50 $ 11.50 Stock Price $ 9.36 $ 9.36 The key inputs into the Black-Scholes Model for the Private Placement Warrants were as follows at initial measurement: Input September 25, 2020 September 30, December 31, Risk-free interest rate 0.12 % 0.42 % 0.36 % Trading days per year 252 252 252 Expected volatility 24.0 % 24.0 % 25.0 % Exercise price $ 11.50 $ 11.50 $ 11.50 Stock Price $ 9.36 $ 9.36 $ 10.08 On September 25, 2020, the Private Placement Warrants and Public Warrants were determined to be $1.36 and $1.28 per warrant, respectively, for aggregate values of $8.2 million and $12.8 million, respectively. Subsequent Measurement The Warrants are measured at fair value on a recurring basis. The subsequent measurement of the Public Warrants as of December 31, 2020 is classified as Level 1 due to the use of an observable market quote in an active market. As of December 31, 2020, the aggregate values of the Private Placement Warrants and Public Warrants were $11.0 million and $11.5 million, respectively. The following table presents the changes in the fair value of warrant liabilities: Private Placement Public Warrant Liabilities Fair value as of September 25, 2020 $ — $ — $ — Initial measurement on September 25, 2020 (IPO) 8,160,000 12,800,000 20,960,000 Change in valuation inputs or other assumptions — 100,000 100,000 Fair value as of September 30, 2020 8,160,000 12,800,000 21,060,000 Measurement on October 1, 2020 (Over-Allotment) 200,518 475,495 676,013 Change in valuation inputs or other assumptions 2,643,400 (1,866,348 ) 777,052 Fair value as of December 31, 2020 $ 11,003,918 $ 11,509,147 $ 22,513,065 Due to the use of quoted prices in an active market (Level 1) to measure the fair value of the Public Warrants, subsequent to initial measurement, the Company had transfers out of Level 3 totaling $13,275,495 during the period from September 25, 2020 through December 31, 2020. Level 3 financial liabilities consist of the Private Placement Warrant liability for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate.

Subsequent Events

Subsequent Events	5 Months Ended
	Dec. 31, 2020
Subsequent Events [Abstract]
Subsequent Events	NOTE 11—SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, other than as described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the consolidated financial statements, with the exception of the following matters: Merger Agreement On January 11, 2021, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”), with Pylon Merger Company LLC, a Delaware limited liability company and a direct wholly-owned subsidiary of the Company (“Merger Sub”), and Bakkt Holdings, LLC, a Delaware limited liability company (“Bakkt”), a transformative digital asset marketplace launched in 2018 by Intercontinental Exchange, Inc. (“ICE”) and a group of investors and strategic partners. The Merger Agreement provides that, among other things and upon the terms and subject to the conditions thereof, the following transactions will occur (together with the other agreements and transactions contemplated by the Merger Agreement, the “Proposed Transaction”): (i) at the closing of the transactions contemplated by the Merger Agreement, Merger Sub will merge (the “Merger”) with and into Bakkt, the separate corporate existence of Merger Sub will cease and Bakkt will be the surviving limited liability company, to be renamed Bakkt Opco Holdings, LLC (“Bakkt Opco”); (ii) immediately prior to the closing of the PIPE Investment and the effective time of the Merger, the Company will be renamed “Bakkt Holdings, Inc.” (referred to hereinafter as “Bakkt Pubco”); and (iii) as a result of the Merger, the aggregate consideration to be received in respect of the Merger by all of the Bakkt interest holders will be an aggregate of 208,200,000 common units of Bakkt Opco (“Bakkt Opco Units”) and 208,200,000 shares of class V common stock of Bakkt PubCo, which will be non-economic, Subscription Agreements On January 11, 2021, concurrently with the execution of the Merger Agreement, the Company entered into subscription agreements (the “Subscription Agreements”) with certain investors (collectively, the “PIPE Investors” which include certain existing equityholders of the Company and Bakkt), pursuant to, and on the terms and subject to the conditions of which, the PIPE Investors have collectively subscribed for 32,500,000 Bakkt Pubco Class A Shares for an aggregate purchase price equal to $325,000,000 (the “PIPE Investment”). The PIPE Investment will be consummated immediately prior to the closing of the Merger Agreement. The Subscription Agreements provide for certain customary registration rights for the PIPE Investors. The Subscription Agreements will terminate with no further force and effect upon the earliest to occur of: (a) such date and time as the Merger Agreement is terminated in accordance with its terms; (b) the mutual written agreement of the parties to such Subscription Agreement; and (c) December 31, 2021.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	5 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC. As described in Note 2—Restatement of Previously Issued Financial Statements, the Company’s consolidated financial statements for the year ended December 31, 2020 (collectively, the “Affected Period”), are restated in this Annual Report on Form 10-K/A (Amendment No. 1) (this “Annual Report”) to correct the misapplication of accounting guidance related to the Company’s warrants in the Company’s previously issued audited and unaudited condensed consolidated financial statements for such periods. The restated consolidated financial statements are indicated as “Restated” in the audited consolidated financial statements and accompanying notes, as applicable. See Note 2—Restatement of Previously Issued Financial Statements for further discussion.
Principles of Consolidation	Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. One of the more significant accounting estimates included in these consolidated financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2020.
Investments held in Trust Account	Investments held in Trust Account The Company’s portfolio of investments held in trust is comprised solely of U.S. Treasury money market funds, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these investments are included in interest earned on marketable securities held in Trust Account in the accompanying consolidated statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at December 31, 2020, 17,312,211 Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ equity section of the Company’s consolidated balance sheet.
Warrant Liability (Restated)	Warrant Liability (Restated) The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as a liability at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the consolidated statements of operations. The fair value of the public warrants were initially estimated using the Option Pricing Method with subsequent remeasurements utilizing the trading stock price, whereas the private warrants were estimated using a Option Pricing Method approach for all periods (see Note 10).
Offering Costs	Offering Costs Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that are directly related to the Initial Public Offering. Offering costs amounting to $11,906,606 were charged to shareholders’ equity upon the completion of the Initial Public Offering.
Derivative Warrant Liabilities	Derivative Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The 10,368,601 warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the 6,147,440 Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s consolidated statement of operations. The fair value of the Public Warrants issued in connection with the Public Offering and Private Placement Warrants were initially measured at fair value using a Option Pricing simulation model and subsequently, the fair value of the Private Placement Warrants have been estimated using a Black Scholes simulation model each measurement date. The fair value of Public Warrants issued in connection with the Initial Public Offering have subsequently been measured based on the listed market price of such warrants.
Income Taxes	Income Taxes The Company accounts for income taxes under ASC Topic 740, “Income Taxes,” which prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of December 31, 2020, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented. The Company does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net Loss Per Ordinary Share (Restated)	The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts): For the Period from Through 2020 Redeemable Class A Ordinary Shares Numerator: Earnings allocable to Redeemable Class A Ordinary Shares Interest Income $ 4,193 Redeemable Net Earnings $ 4,193 Denominator: Weighted Average Redeemable Class A Ordinary Shares Redeemable Class A Ordinary Shares, Basic and Diluted 20,737,202 Net Income Per Share/Basic and Diluted Redeemable Class A Ordinary Shares $ — Non-Redeemable Numerator: Net Income (Loss) minus Redeemable Net Earnings Net Income (Loss) $ (4,861,190 ) Redeemable Net Earnings $ (4,193 ) Non-Redeemable $ (4,865,383 ) Denominator: Weighted Average Non-Redeemable Class B Ordinary Share s Non-Redeemable 5,184,300 Net Loss Per Share/Basic and Diluted Non-Redeemable s $ (0.94 ) As of December 31, 2020, The Company has not considered the effect of the warrants sold in the Initial Public Offering and Private Placement to purchase an aggregate of 16,000,000 shares of Class A common stock in the calculation of diluted loss per share, since their inclusion would be antidilutive under the treasury stock method. As a result, diluted loss per common share is the same as basic loss per common share for the period presented.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limits of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities other than the warrant liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the Company’s consolidated balance sheet, primarily due to their short-term nature.
Fair Value Measurements (Restated)	Fair Value Measurements (Restated) Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Derivative Financial Instruments (Restated)	Derivative Financial Instruments (Restated) The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.
Recent Accounting Standards	Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s consolidated financial statements.

Restatement of Previously Iss_2

Restatement of Previously Issued Financial Statements (Tables)	5 Months Ended
	Dec. 31, 2020
Restatement Of Previously Issued Financial Statements [Abstract]
Summary of Restatement of Warrants in Financial Statements	The Company’s accounting for the warrants as components of equity instead of as derivative liabilities did not have any effect on the Company’s previously reported operating expenses, cash flows or cash. Balance Sheet as of September 25, 2020 (audited) As Reported Restatement As Restated Warrant Liabilities $ — $ 20,960,000 $ 20,960,000 Total Liabilities 7,002,230 20,960,000 27,962,230 Class A ordinary shares subject to possible redemption 189,517,240 (20,960,000 ) 168,557,240 Class A ordinary shares 105 209 314 Additional paid-in capital $ 5,005,991 $ 2,914,781 $ 7,920,772 Accumulated deficit $ (6,606 ) $ (2,914,990 ) $ (2,921,596 ) Total Shareholders’ Equity $ 5,000,008 $ — $ 5,000,008 Number of shares subject to possible redemption 18,951,724 (2,096,000 ) 16,855,724 Balance Sheet as of September 30, 2020 (unaudited) Warrant Liabilities $ — $ 21,060,000 $ 21,060,000 Total Liabilities 7,002,230 21,060,000 28,062,230 Class A ordinary shares subject to possible redemption 189,506,470 (21,060,000 ) 168,446,470 Class A ordinary shares 105 211 316 Additional paid-in capital $ 5,016,761 $ 3,014,779 $ 8,031,540 Accumulated deficit (17,379 ) (3,014,990 ) (3,032,369 ) Total Shareholders’ Equity $ 5,000,005 $ — $ 5,000,005 Number of shares subject to possible redemption 18,950,647 (2,106,000 ) 16,844,647 Balance Sheet as of December 31, 2020 (audited) Warrant Liabilities $ — $ 22,513,065 $ 22,513,065 Total Liabilities 8,153,666 22,513,065 30,666,731 Class A ordinary shares subject to possible redemption 195,635,180 (22,513,070 ) 173,122,110 Class A ordinary shares 118 225 343 Additional paid-in capital $ 6,002,037 $ 3,858,301 $ 9,860,338 Accumulated deficit $ (1,002,669 ) $ (3,858,521 ) $ (4,861,190 ) Total Shareholders’ Equity $ 5,000,004 $ 5 $ 5,000,009 Number of shares subject to possible redemption 19,563,518 (2,251,306 ) 17,312,211 Statement of Operations for the period from July 31, 2020 (Inception) As Reported Restatement As Restated Transaction costs allocable to warrant liabilities $ — $ (754,990 ) $ (754,990 ) Change in fair value of warrant liabilities — (2,260,000 ) (2,260,000 ) Net loss $ (17,379 ) $ (3,014,990 ) $ (3,032,369 ) Basic and diluted net loss per share, Class B $ 0.00 $ (0.58 ) $ (0.58 ) Statement of Operations for the period from July 31, 2020 (Inception) Transaction costs allocable to warrant liabilities $ — $ (768,391 ) $ (768,391 ) Change in fair value of warrant liabilities — (3,090,130 ) (3,090,130 ) Net loss $ (1,002,669 ) $ (3,858,521 ) $ (4,861,190 ) Basic and diluted net (loss) per ordinary share, Class B $ (0.19 ) $ (0.75 ) $ (0.94 ) Statement of Cash Flows for the period from July 31, 2020 (inception) As Reported Restatement As Restated Net loss $ (17,379 ) $ (3,014,990 ) $ (3,032,369 ) Transaction costs allocable to warrant liabilities $ — $ (754,990 ) $ (754,990 ) Change in fair value of warrant liabilities — (2,260,000 ) (2,260,000 ) Initial classification of Class A Ordinary Shares subject to possible redemption 189,517,240 (20,960,000 ) 168,557,240 Change in value of Class A Ordinary Shares subject to possible redemption (10,770 ) (100,000 ) (110,770 ) Initial classification of warrant liability $ — $ 20,960,000 $ 20,960,000 Statement of Cash Flows for the period from July 31, 2020 (inception) As Reported Restatement As Restated Net loss $ (1,002,669 ) $ (3,858,521 ) $ (4,861,190 ) Transaction costs allocable to warrant liabilities $ — $ (768,391 ) $ (768,391 ) Change in fair value of warrant liabilities — (3,090,130 ) (3,090,130 ) Initial classification of Class A Ordinary Shares subject to possible redemption 196,631,240 (21,748,230 ) 174,883,010 Change in value of Class A Ordinary Shares subject to possible redemption (996,060 ) (764,840 ) (1,760,900 ) Initial classification of warrant liability $ — $ 20,960,000 $ 20,960,000

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	5 Months Ended
	Dec. 31, 2020
Earnings Per Share [Abstract]
Schedule of Earnings Per Share Basic And Diluted	The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts): For the Period from Through 2020 Redeemable Class A Ordinary Shares Numerator: Earnings allocable to Redeemable Class A Ordinary Shares Interest Income $ 4,193 Redeemable Net Earnings $ 4,193 Denominator: Weighted Average Redeemable Class A Ordinary Shares Redeemable Class A Ordinary Shares, Basic and Diluted 20,737,202 Net Income Per Share/Basic and Diluted Redeemable Class A Ordinary Shares $ — Non-Redeemable Numerator: Net Income (Loss) minus Redeemable Net Earnings Net Income (Loss) $ (4,861,190 ) Redeemable Net Earnings $ (4,193 ) Non-Redeemable $ (4,865,383 ) Denominator: Weighted Average Non-Redeemable Class B Ordinary Share s Non-Redeemable 5,184,300 Net Loss Per Share/Basic and Diluted Non-Redeemable $ (0.94 )

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	5 Months Ended
	Dec. 31, 2020
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair Value, Assets Measured on Recurring Basis	The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at December 31, 2020 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level December 31, 2020 Assets: Investments held in Trust Account—U.S. Treasury Securities Money Market Fund 1 $ 207,376,213 Liabilities: Warrant Liability—Public Warrants 1 $ 11,509,147 Warrant Liability—Private Placement Warrants 3 $ 11,003,918
Summary Of Reconciliation Of Warrant Liabilities Measured At Fair Value	The following table presents the changes in the fair value of warrant liabilities: Private Placement Public Warrant Liabilities Fair value as of September 25, 2020 $ — $ — $ — Initial measurement on September 25, 2020 (IPO) 8,160,000 12,800,000 20,960,000 Change in valuation inputs or other assumptions — 100,000 100,000 Fair value as of September 30, 2020 8,160,000 12,800,000 21,060,000 Measurement on October 1, 2020 (Over-Allotment) 200,518 475,495 676,013 Change in valuation inputs or other assumptions 2,643,400 (1,866,348 ) 777,052 Fair value as of December 31, 2020 $ 11,003,918 $ 11,509,147 $ 22,513,065
Public Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Summary Of Quantitative Information Regarding Fair Value Measurements Of Warrants	The key inputs into the Option Pricing Method for the Public Warrants were as follows at initial measurement: Input September 25, 2020 September 30, Risk-free interest rate 0.26 % 0.28 % Trading days per year 252 252 Expected volatility 24.0 % 24.0 % Exercise price $ 11.50 $ 11.50 Stock Price $ 9.36 $ 9.36
Private Placement Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Summary Of Quantitative Information Regarding Fair Value Measurements Of Warrants	The key inputs into the Black-Scholes Model for the Private Placement Warrants were as follows at initial measurement: Input September 25, 2020 September 30, December 31, Risk-free interest rate 0.12 % 0.42 % 0.36 % Trading days per year 252 252 252 Expected volatility 24.0 % 24.0 % 25.0 % Exercise price $ 11.50 $ 11.50 $ 11.50 Stock Price $ 9.36 $ 9.36 $ 10.08

Description of Organization a_2

Description of Organization and Business Operations - Additional Information (Details) - USD ($)	Oct. 01, 2020	Sep. 25, 2020	Aug. 03, 2020	Dec. 31, 2020	Dec. 31, 2020	Jul. 30, 2020
Number of units issued				$ 182,958,309
Proceeds from warrants issued				6,147,440
Stock issued, transaction costs		$ 11,906,606
Underwriting fees		4,147,440
Deferred underwriting fees		7,258,021
Other offering costs		501,145
Cash held		1,205,178		$ 1,177,678	$ 1,177,678
Percentage Of Assets Held in Trust Account				80.00%	80.00%
Percent Of Shares Restricted For Redemption				15.00%	15.00%
Minimum Net Tangible Assets Required For Business Combination				$ 5,000,001	$ 5,000,001
Percent of Shares Redeemable				100.00%	100.00%
Interest On Dissolution Expenses				$ 100,000
Working capital				500,000	$ 500,000
Working capital loans outstanding				0	0
Stock shares issued during the period value for services rendered				$ 25,000
Pylon Merger Company LLC [Member]
Entity Incorporation, Date of Incorporation				Dec. 18, 2020
Sponsor [Member]
Debt instrument face value				$ 300,000	300,000
Class B [Member] | Founder Shares [Member]
Stock shares issued during the period value for services rendered			$ 25,000		$ 25,000
Trust Account member [Member]
Share Price				$ 10	$ 10
Minimum [Member]
Equity Method Investment, Ownership Percentage				50.00%	50.00%
Share Price				$ 10	$ 10
Minimum [Member] | Trust Account member [Member]
Share Price				$ 10	$ 10
IPO [Member]
Number of units issued		20,000,000
Gross proceeds from units issued		$ 200,000,000
Shares issued, price per share		$ 10
Private Placement Warrants [Member]
Number of warrants issued		6,000,000
Number of warrants issued, price per share		$ 1
Proceeds from warrants issued		$ 6,000,000
Over-Allotment Option [Member]
Number of units issued	$ 737,202
Number of warrants issued	147,440
Number of warrants issued, price per share	$ 1
Proceeds from warrants issued	$ 7,519,460
Shares issued, price per share	$ 10

Restatement of Previously Iss_3

Restatement of Previously Issued Financial Statements - Summary of Restatement of Warrants in Financial Statements (Detail) - USD ($)	2 Months Ended	5 Months Ended
	Sep. 30, 2020	Dec. 31, 2020	Sep. 25, 2020	Jul. 30, 2020
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Warrant liabilities		$ 22,513,065
Total Liabilities		30,666,731
Class A ordinary shares subject to possible redemption		173,122,110
Additional paid-in capital		9,860,338
Accumulated deficit		(4,861,190)
Total Shareholders' Equity		5,000,009		$ 0
Transaction Costs allocable to warrant liabilities		(768,391)
Change in fair value of warrant liabilities		(3,090,130)
Net loss		(4,861,190)
Initial classification of Class A ordinary shares subject to possible redemption		174,883,010
Change in value of Class A ordinary shares subject to possible redemption		(1,760,900)
Initial classification of warrant liabilities		20,960,000
As Reported
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Warrant liabilities	$ 0	0	$ 0
Total Liabilities	7,002,230	8,153,666	7,002,230
Additional paid-in capital	5,016,761	6,002,037	5,005,991
Accumulated deficit	(17,379)	(1,002,669)	(6,606)
Total Shareholders' Equity	$ 5,000,005	$ 5,000,004	$ 5,000,008
Number of shares subject to possible redemption	18,950,647	19,563,518	18,951,724
Transaction Costs allocable to warrant liabilities	$ 0	$ 0
Change in fair value of warrant liabilities	0	0
Net loss	(17,379)	(1,002,669)
Initial classification of Class A ordinary shares subject to possible redemption	189,517,240	196,631,240
Change in value of Class A ordinary shares subject to possible redemption	(10,770)	(996,060)
Initial classification of warrant liabilities	0	0
Restatement
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Warrant liabilities	21,060,000	22,513,065	$ 20,960,000
Total Liabilities	21,060,000	22,513,065	20,960,000
Additional paid-in capital	3,014,779	3,858,301	2,914,781
Accumulated deficit	(3,014,990)	(3,858,521)	(2,914,990)
Total Shareholders' Equity	$ 0	$ 5	$ 0
Number of shares subject to possible redemption	(2,106,000)	(2,251,306)	(2,096,000)
Transaction Costs allocable to warrant liabilities	$ (754,990)	$ (768,391)
Change in fair value of warrant liabilities	(2,260,000)	(3,090,130)
Net loss	(3,014,990)	(3,858,521)
Initial classification of Class A ordinary shares subject to possible redemption	(20,960,000)	(21,748,230)
Change in value of Class A ordinary shares subject to possible redemption	(100,000)	(764,840)
Initial classification of warrant liabilities	20,960,000	20,960,000
As Restated
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Warrant liabilities	21,060,000	22,513,065	$ 20,960,000
Total Liabilities	28,062,230	30,666,731	27,962,230
Additional paid-in capital	8,031,540	9,860,338	7,920,772
Accumulated deficit	(3,032,369)	(4,861,190)	(2,921,596)
Total Shareholders' Equity	$ 5,000,005	$ 5,000,009	$ 5,000,008
Number of shares subject to possible redemption	16,844,647	17,312,211	16,855,724
Transaction Costs allocable to warrant liabilities	$ (754,990)	$ (768,391)
Change in fair value of warrant liabilities	(2,260,000)	(3,090,130)
Net loss	(3,032,369)	(4,861,190)
Initial classification of Class A ordinary shares subject to possible redemption	168,557,240	174,883,010
Change in value of Class A ordinary shares subject to possible redemption	(110,770)	(1,760,900)
Initial classification of warrant liabilities	20,960,000	20,960,000
Class A [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Class A ordinary shares		$ 343
Number of shares subject to possible redemption		17,312,211
Basic and diluted net (loss) per share		$ 0
Class A [Member] | As Reported
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Class A ordinary shares subject to possible redemption	189,506,470	$ 195,635,180	$ 189,517,240
Class A ordinary shares	105	118	105
Class A [Member] | Restatement
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Class A ordinary shares subject to possible redemption	(21,060,000)	(22,513,070)	(20,960,000)
Class A ordinary shares	211	225	209
Class A [Member] | As Restated
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Class A ordinary shares subject to possible redemption	168,446,470	173,122,110	168,557,240
Class A ordinary shares	$ 316	343	$ 314
Class B [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Class A ordinary shares		518
Net loss		$ (4,861,190)
Basic and diluted net (loss) per share		$ (0.94)
Class B [Member] | As Reported
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Basic and diluted net (loss) per share	$ 0	(0.19)
Class B [Member] | Restatement
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Basic and diluted net (loss) per share	(0.58)	(0.75)
Class B [Member] | As Restated
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Basic and diluted net (loss) per share	$ (0.58)	$ (0.94)

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)	Sep. 25, 2020	Dec. 31, 2020	Oct. 01, 2020
Cash equivalents		$ 0
Offering costs charged to equity	$ 11,906,606
Unrecognized Tax Benefits		0
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued		0
Interest earned on investments held in Trust Account		4,193
FDIC Insured Amount		$ 250,000
Temporary Equity, Shares Authorized		17,312,211
Private Placement Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		16,000,000
IPO [Member] | Public Warrants [Member]
Number of warrants issued		10,368,601
Private Placement [Member] | Private Placement Warrants [Member]
Number of warrants issued		6,147,440
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		16,516,041

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Schedule of Earnings Per Share Basic And Diluted (Detail)	5 Months Ended
	Dec. 31, 2020USD ($)$ / sharesshares
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest [Abstract]
Interest Income	$ 4,193
Numerator: Net Income (Loss) minus Redeemable Net Earnings
Net Income (Loss)	(4,861,190)
Non-Redeemable Net Loss	(1,006,862)
Common Class A [Member]
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest [Abstract]
Interest Income	4,193
Redeemable Net Earnings	$ 4,193
Denominator: Weighted Average Redeemable Class A Ordinary Shares
Redeemable Class A Ordinary Shares, Basic and Diluted | shares	20,737,202
Net Income Per Share/Basic and Diluted Redeemable Class A Ordinary Shares | $ / shares	$ 0
Numerator: Net Income (Loss) minus Redeemable Net Earnings
Redeemable Net Earnings	$ 4,193
Denominator: Weighted Average Non-Redeemable Class B Ordinary Shares
Non-Redeemable Class B Ordinary Shares, Basic and Diluted | shares	20,737,202
Net Loss Per Share/Basic and Diluted Non-Redeemable Class B Ordinary Shares | $ / shares	$ 0
Common Class B [Member]
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest [Abstract]
Redeemable Net Earnings	$ (4,193)
Denominator: Weighted Average Redeemable Class A Ordinary Shares
Redeemable Class A Ordinary Shares, Basic and Diluted | shares	5,184,300
Net Income Per Share/Basic and Diluted Redeemable Class A Ordinary Shares | $ / shares	$ (0.94)
Numerator: Net Income (Loss) minus Redeemable Net Earnings
Net Income (Loss)	$ (4,861,190)
Redeemable Net Earnings	(4,193)
Non-Redeemable Net Loss	$ (4,865,383)
Denominator: Weighted Average Non-Redeemable Class B Ordinary Shares
Non-Redeemable Class B Ordinary Shares, Basic and Diluted | shares	5,184,300
Net Loss Per Share/Basic and Diluted Non-Redeemable Class B Ordinary Shares | $ / shares	$ (0.94)

Initial Public offering - Addit

Initial Public offering - Additional Information (Detail) - USD ($)	Oct. 01, 2020	Sep. 25, 2020	Dec. 31, 2020
Disclosure Of Initial Public Offer [Line Items]
Number of units issued			$ 182,958,309
Exercise price of warrants		$ 11.50
Public Warrants [Member]
Disclosure Of Initial Public Offer [Line Items]
Number Of Securities Called By Each Warrant Or Right	1
Exercise price of warrants	$ 11.50	$ 1.28
IPO [Member]
Disclosure Of Initial Public Offer [Line Items]
Number of units issued		$ 20,000,000
Shares issued, price per share		$ 10
Over-Allotment Option [Member]
Disclosure Of Initial Public Offer [Line Items]
Number of units issued	$ 737,202
Shares issued, price per share	$ 10

Private Placement - Additional

Private Placement - Additional Information (Details) - USD ($)	Oct. 01, 2020	Sep. 25, 2020	Dec. 31, 2020
Private Placement [Line Items]
Proceeds from warrants issued			$ 6,147,440
Exercise price of warrants		$ 11.50
Private Placement Warrants [Member]
Private Placement [Line Items]
Proceeds from warrants issued		$ 6,000,000
Private Placement Warrants [Member] | Private Placement [Member]
Private Placement [Line Items]
Number of warrants issued	147,440	6,000,000
Number of warrants issued, price per share	$ 1		$ 1

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Details) - USD ($)	Oct. 01, 2020	Sep. 25, 2020	Aug. 03, 2020	Dec. 31, 2020	Dec. 31, 2020	Dec. 31, 2020
Related Party Transaction [Line Items]
Stock shares issued during the period value for services rendered					$ 25,000
Share based compensation other than employee stock scheme shares forfeited during the period					565,700
Repayment of related party debt					$ 82,729
Minimum [Member]
Related Party Transaction [Line Items]
Share Price				$ 10	$ 10	$ 10
Sponsor [Member]
Related Party Transaction [Line Items]
Debt instrument face value			$ 300,000
Debt instrument maturity date						Dec. 31, 2020
Sponsor [Member] | Working Capital Loans [Member]
Related Party Transaction [Line Items]
Working capital loan convertible into warrants				$ 1,500,000	$ 1,500,000	$ 1,500,000
Debt instrument conversion price				$ 1	$ 1	$ 1
Working capital loans outstanding				$ 0	$ 0	$ 0
Sponsor [Member] | Administrative Support Agreement [Member]
Related Party Transaction [Line Items]
Related party transaction expenses				10,000
Due to officers or stockholders, current				$ 30,000	$ 30,000	$ 30,000
Founder Shares [Member]
Related Party Transaction [Line Items]
Repayment of related party debt		$ 82,729
Founder Shares [Member] | Lock In Period One [Member]
Related Party Transaction [Line Items]
Lock in period after business combination founder shares					1 year
Founder Shares [Member] | Lock In Period Two [Member] | Minimum [Member]
Related Party Transaction [Line Items]
Lock in period after business combination founder shares					150 days
Class A [Member]
Related Party Transaction [Line Items]
Common Stock, Shares, Outstanding				3,424,991	3,424,991	3,424,991
Class A [Member] | Founder Shares [Member]
Related Party Transaction [Line Items]
Percentage of common stock shares outstanding				20.00%	20.00%	20.00%
Number of consecutive trading days for determining the share price					20 days
Number of trading days for determining the share price					30 days
Class A [Member] | Founder Shares [Member] | Minimum [Member]
Related Party Transaction [Line Items]
Share Price				$ 12	$ 12	$ 12
Class B [Member]
Related Party Transaction [Line Items]
Common Stock, Shares, Outstanding				5,184,300	5,184,300	5,184,300
Class B [Member] | Founder Shares [Member]
Related Party Transaction [Line Items]
Stock shares issued during the period shares for services rendered			5,750,000
Stock shares issued during the period value for services rendered			$ 25,000			$ 25,000
Common Stock, Shares, Outstanding			5,690,000	5,184,300	5,184,300	5,184,300
Common stock share subject to forfeiture					750,000
Percentage of common stock shares outstanding				20.00%	20.00%	20.00%
Share based compensation other than employee stock scheme shares forfeited during the period	565,700
Common stock shares not subject to forfeiture				184,300	184,300	184,300
Class B [Member] | Founder Shares [Member] | Board Of Directors [Member]
Related Party Transaction [Line Items]
Shares transferred to related party			60,000

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details)	Dec. 31, 2020USD ($)$ / shares
Commitments And Contingencies [Line Items]
Deferred underwriting fee payable	$ 7,258,021
Underwriting Agreement [Member]
Commitments And Contingencies [Line Items]
Deferred underwriting fee payable per share | $ / shares	$ 0.35
Deferred underwriting fee payable	$ 7,258,021

Shareholders' Equity - Addition

Shareholders' Equity - Additional Information (Details)	5 Months Ended
	Dec. 31, 2020$ / sharesshares	Aug. 03, 2020shares
Subsidiary or Equity Method Investee [Line Items]
Preferred stock shares authorized	1,000,000
Preferred Stock par or stated value per share | $ / shares	$ 0.0001
Preferred Stock, Shares Issued	0
Preferred Stock, Shares Outstanding	0
Class A [Member]
Subsidiary or Equity Method Investee [Line Items]
Common Stock, Shares Authorized	200,000,000
Common stock description of voting rights	one vote
Common Stock, Par Value | $ / shares	$ 0.0001
Common Stock, Shares, Issued	3,424,991
Common Stock, Shares, Outstanding	3,424,991
Temporary equity shares outstanding	17,312,211
Class A [Member] | Non-US [Member]
Subsidiary or Equity Method Investee [Line Items]
Common stock description of voting rights	ten votes per share
Class A [Member] | Founder Shares [Member]
Subsidiary or Equity Method Investee [Line Items]
Percentage of common stock shares outstanding	20.00%
Class B [Member]
Subsidiary or Equity Method Investee [Line Items]
Common Stock, Shares Authorized	20,000,000
Common stock description of voting rights	one vote
Common Stock, Par Value | $ / shares	$ 0.0001
Common Stock, Shares, Issued	5,184,300
Common Stock, Shares, Outstanding	5,184,300
Common stock shares converion ratio from class of common stock to other	1
Class B [Member] | Non-US [Member]
Subsidiary or Equity Method Investee [Line Items]
Common stock description of voting rights	one vote per share
Class B [Member] | Founder Shares [Member]
Subsidiary or Equity Method Investee [Line Items]
Common Stock, Shares, Outstanding	5,184,300	5,690,000
Percentage of common stock shares outstanding	20.00%

Warrants - Additional Informati

Warrants - Additional Information (Details)	5 Months Ended
	Dec. 31, 2020$ / shares
Subsidiary or Equity Method Investee [Line Items]
Class of warrants or rights term	5 years
Sale of stock issue price per share	$ 9.20
Event Trigerring The Value Of Warrants [Member]
Subsidiary or Equity Method Investee [Line Items]
Share Price	$ 9.20
Number of consecutive trading days for determining the share price	10 days
Percentage of gross proceeds from share issue for the purposes of business combination	60.00%
Event Trigerring The Value Of Warrants [Member] | Market Value [Member]
Subsidiary or Equity Method Investee [Line Items]
Redemption price of warrants in percentage	115.00%
Redemption price of common stock percentage	180.00%
Event Trigerring The Value Of Warrants [Member] | Newly Issued Price [Member]
Subsidiary or Equity Method Investee [Line Items]
Redemption price of warrants in percentage	115.00%
Redemption price of common stock percentage	180.00%
Minimum [Member]
Subsidiary or Equity Method Investee [Line Items]
Share Price	$ 10
Triggering Share Price One [Member] | Maximum [Member]
Subsidiary or Equity Method Investee [Line Items]
Share Price	$ 18
Number of consecutive trading days for determining the share price	20 days
Number of trading days for determining the share price	30 days
Number of days prior to the date of notifying the warrant holders for determining the total trading period	3 days
Triggering Share Price One [Member] | Minimum [Member]
Subsidiary or Equity Method Investee [Line Items]
Share Price	$ 18
Number of days of notice to be given for the redemption of warrants	30 days
Number of consecutive trading days for determining the share price	20 days
Number of trading days for determining the share price	30 days
Number of days prior to the date of notifying the warrant holders for determining the total trading period	3 days
Triggering Share Price One [Member] | Minimum [Member] | Warrant Redemption Price One [Member]
Subsidiary or Equity Method Investee [Line Items]
Class of warrants or rights redemption price	$ 0.01
Triggering Share Price Two [Member] | Minimum [Member]
Subsidiary or Equity Method Investee [Line Items]
Share Price	$ 10
Number of days of notice to be given for the redemption of warrants	30 days
Number of consecutive trading days for determining the share price	20 days
Number of trading days for determining the share price	30 days
Number of days prior to the date of notifying the warrant holders for determining the total trading period	3 days
Triggering Share Price Two [Member] | Minimum [Member] | Warrant Redemption Price Two [Member]
Subsidiary or Equity Method Investee [Line Items]
Class of warrants or rights redemption price	$ 0.10
Warrant Excercise Period One [Member]
Subsidiary or Equity Method Investee [Line Items]
Class of warrants or rights number of days from the closure of business combination within which excersing can be done	30 days
Warrant Excercise Period Two [Member]
Subsidiary or Equity Method Investee [Line Items]
Class of warrants or rights number of days from the closure of business combination within which excersing can be done	1 year
Private Placement Warrants And Class A Stock Issuable Upon Exercise Of Private Placement Warrants [Member]
Subsidiary or Equity Method Investee [Line Items]
Class of warrants or rights lock in period	30 days

FAIR VALUE MEASUREMENTS - Fair

FAIR VALUE MEASUREMENTS - Fair Value, Assets Measured on Recurring Basis (Detail) - Fair Value, Recurring [Member]	Dec. 31, 2020USD ($)
Fair Value, Inputs, Level 1 [Member] | Public Warrants [Member]
Liabilities, Fair Value Disclosure [Abstract]
Warrant Liability—Public Warrants	$ 11,509,147
Fair Value, Inputs, Level 3 [Member] | Private Placement Warrants [Member]
Liabilities, Fair Value Disclosure [Abstract]
Warrant Liability—Private Placement Warrants	11,003,918
US Treasury Securities [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments held in Trust Account – U.S. Treasury Securities Money Market Fund	$ 207,376,213

FAIR VALUE MEASUREMENTS - Summa

FAIR VALUE MEASUREMENTS - Summary Of Quantitative Information Regarding Fair Value Measurements Of Warrants (Detail) - $ / shares	Sep. 25, 2020	Sep. 30, 2020	Dec. 31, 2020
Option Pricing Method | Risk-free interest rate | Public Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Risk-free interest rate	0.26%	0.28%
Option Pricing Method | Trading days per year | Public Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Trading days per year	252.00%	252.00%
Option Pricing Method | Expected volatility | Public Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Expected volatility	24.00%	24.00%
Option Pricing Method | Exercise price | Public Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Exercise price	$ 11.50	$ 11.50
Option Pricing Method | Stock Price | Public Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Stock Price	$ 9.36	$ 9.36
Black Scholes Model | Risk-free interest rate | Private Placement Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Risk-free interest rate	0.12%	0.42%	0.36%
Black Scholes Model | Trading days per year | Private Placement Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Trading days per year	252.00%	252.00%	252.00%
Black Scholes Model | Expected volatility | Private Placement Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Expected volatility	24.00%	24.00%	25.00%
Black Scholes Model | Exercise price | Private Placement Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Exercise price	$ 11.50	$ 11.50	$ 11.50
Black Scholes Model | Stock Price | Private Placement Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Stock Price	$ 9.36	$ 9.36	$ 10.08

FAIR VALUE MEASUREMENTS - Sum_2

FAIR VALUE MEASUREMENTS - Summary Of Reconciliation Of Warrant Liabilities Measured At Fair Value (Detail) - Fair Value, Inputs, Level 1 [Member] - USD ($)	Sep. 30, 2020	Dec. 31, 2020
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value, beginning balance		$ 21,060,000
Change in valuation inputs or other assumptions	100,000	777,052
Fair value, ending balance	21,060,000	22,513,065
Public Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value, beginning balance		12,800,000
Change in valuation inputs or other assumptions	100,000	(1,866,348)
Fair value, ending balance	12,800,000	11,509,147
Private Placement Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value, beginning balance		8,160,000
Change in valuation inputs or other assumptions		2,643,400
Fair value, ending balance	8,160,000	11,003,918
IPO [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Measurement	20,960,000
IPO [Member] | Public Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Measurement	12,800,000
IPO [Member] | Private Placement Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Measurement	$ 8,160,000
Over-Allotment Option [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Measurement		676,013
Over-Allotment Option [Member] | Public Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Measurement		475,495
Over-Allotment Option [Member] | Private Placement Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Measurement		$ 200,518

FAIR VALUE MEASUREMENTS - Addit

FAIR VALUE MEASUREMENTS - Additional Information (Detail) - USD ($)	3 Months Ended
	Dec. 31, 2020	Oct. 01, 2020	Sep. 25, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets held in trust non current	$ 207,376,213
Class of warrants, exercise price per share			$ 11.50
Fair value, measurement with unobservable inputs reconciliation, liability, transfers out of level 3	13,275,495
Private Placement Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Class of warrants, exercise price per share			$ 1.36
Warrants outstanding	11,000,000		$ 8,200,000
Public Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Class of warrants, exercise price per share		$ 11.50	$ 1.28
Warrants outstanding	11,500,000		$ 12,800,000
US Treasury Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets held in trust non current	$ 207,376,213

Subsequent Events - Additional

Subsequent Events - Additional Information (Detail) - USD ($)	Jan. 11, 2021	Dec. 31, 2020
Subsequent Event [Line Items]
Proceeds from Issuance of Common Stock		$ 203,224,580
Bakkt Pubco Class A Shares [Member] | Baktt Opco Units [Member]
Subsequent Event [Line Items]
Stock shares issued during the period new issue shares		20,737,202
Subsequent Event [Member] | Baktt Opco Units [Member] | Merger Agreement [Member]
Subsequent Event [Line Items]
Stock shares issued during the period new issue shares	208,200,000
Subsequent Event [Member] | Bakkt Pubco Class A Shares [Member] | Subscription Agreement [Member] | PIPE Investor [Member]
Subsequent Event [Line Items]
Stock shares issued during the period new issue shares	32,500,000
Proceeds from Issuance of Common Stock	$ 325,000,000
Subsequent Event [Member] | Baktt Pubco Class V Common Stock [Member] | Merger Agreement [Member]
Subsequent Event [Line Items]
Stock shares issued during the period new issue shares	208,200,000